Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization.

Authors:
Guo H; Fan Q; Song S; Shen S; Zhou B and 5 more

Journal:
J Clin Virol

Publication Year: 2022

DOI:
10.1016/j.jcv.2022.105162

PMCID:
PMC9007935

PMID:
35461042

Journal Information

Full Title: J Clin Virol

Abbreviation: J Clin Virol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Virology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interests The authors have no conflict of interest."

Evidence found in paper:

"We thank all participants who recovered from COVID-19 and who received inactivated vaccine and all of the healthy providers from Shenzhen Third People's Hospital for the work they have done. This study was supported by the 10.13039/501100014219National Science Fund for Distinguished Young Scholars (82025022), the National Natural Science Foundation of China (82002140, 82171752, 82101861), the Guangdong Basic and Applied Basic Research Foundation (2021B1515020034, 2019A1515011197, 2021A1515011009, 2020A1515110656), and the 10.13039/501100017610Shenzhen Science and Technology Program (RCYX20200714114700046, JSGG20200207155251653, JSGG20200807171401008, KQTD20200909113758004, JCYJ20190809115617365)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025